This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Alnylam Pharmaceuticals Inc
ALNY : NASDAQ : Health Care
$55.86 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 925,600
07/23/14 - 3:59 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
ALNY ALNYLAM PHARMACEUTICALS INC 52.02 3930.27 n/m 36.80 -43.20
CBST CUBIST PHARMACEUTICALS INC 63.24 4762.29 n/m 1085.75 14.94
ICPT INTERCEPT PHARMA INC 210.36 4448.27 n/m 1.62 21.68
UTHR UNITED THERAPEUTICS CORP 89.74 4304.74 19.85 1161.25 21.34
SGEN SEATTLE GENETICS INC 33.75 4156.18 n/m 280.21 27.42
ITMN INTERMUNE INC 40.59 4013.66 n/m 90.08 183.06
IDIX IDENIX PHARMACEUTICALS INC 24.04 3626.58 n/m -3.39 -109.72
OPK OPKO HEALTH INC 8.60 3558.26 n/m 87.43 25.53
ISIS ISIS PHARMACEUTICALS INC 27.54 3238.07 n/m 132.09 8.11
CPHD CEPHEID INC 46.19 3220.20 n/m 436.75 21.03
NPSP NPS PHARMACEUTICALS INC 26.94 2864.42 n/m 174.20 30.82
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

ALNY Ind Avg S&P 500
n/m 52.05 19.42
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs